Ethics Approval for Clarity’s SARTATE™ Kids Clinical Trial
Sydney, Australia 15 August 2017 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has been granted Ethics Approval by The Children’s Hospital at Westmead for its SARTATE™ Kids clinical trial for neuroblastoma. Clarity filed its ethics submission to the Sydney Children’s Hospital Network Human…